Incorporating Topical and Oral Treatments into Practice

Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.

Focusing on Safety Considerations for the Prescription of JAK Inhibitors

After reviewing notable safety considerations for systemic and topical Janus kinase inhibitors for patients with atopic dermatitis, Nicole Keeter, PA-C, describes steps she has taken to become more comfortable prescribing these agents to her patients with AD and discusses important tips for counseling these patients on adverse events and black box warnings.

Safety of Topical JAK Inhibitors for Atopic Dermatitis

Douglas DiRuggiero, DMSc, PA-C, discusses the exciting renaissance occurring in the realm of topical treatments for atopic dermatitis. 

An Overview of Janus-kinase (JAK) inhibitors for Atopic Dermatitis

Douglas DiRuggiero, DMSc, PA-C, discusses the mechanism of action and efficacy of topical and systemic JAK inhibitors for the treatment of atopic dermatitis. 

Navigating the Landscape of New Atopic Dermatitis Therapies

Margaret Bobonich, CNP, DNP, discusses new therapies for the management of atopic dermatitis and provides her perspective on how NPs and PAs can navigate the use of these new treatments.